INSIGHTS ON DRUG DISCOVERY

Solving The Inhalation Puzzle: A CDMO's Guide To Dry Powder Development
Gain guidance on the choice of formulation, excipients, and the micronization technologies offered by CDMOs, and learn about current encapsulation technologies for inhaled products.
Drug Development And Delivery Tech Talks
Tailored drug release is evolving from formulation tactic to precision therapy strategy, optimizing timing, site, and rate of delivery for improved patient outcomes.
Securing A Treatment Through Grit And Collaboration
Discover how one family defied the odds—bringing a lifesaving gene therapy from idea to treatment in just 14 months after a devastating rare disease diagnosis.
Creating Your ADC Supply Chain
Antibody-drug conjugates (ADCs) are on the rise. Supply chains to serve ADC developers can be complicated, and spread out. Reza Oliyai has some key interpretations of how these therapies can string together optimal - and at times far-reaching - supply chains.

Your CDMO Knows A Lot - Are You Listening?
6/26/2025

Our three experienced panelists weigh in on how sponsors should take advantage of what CDMOs know from experience in quality, regulatory, and other aspects of development and processing.
CDMO SOWs Must (Re-)Align With New Project Realities
6/26/2025

Decades of experience in cell and gene therapy outsourcing have taught Donna Rill, Chief Technology Officer, Triumvira Immunologics, that the key to success is ensuring CDMOs and sponsors understand the need to continuously align SOWs with the variances as projects move forward.
Where CDMOs Can Improve For CGT Customers?
6/26/2025

Donna Rill, Chief Technology Officer, Triumvira Immunologics, has advice for CDMOs to improve their service to CGT customers, and conversely, where drug developers can improve as well.
Are You Asking For Unrealistic Flexibility At Your CDMO?
6/26/2025

Our experienced Outsourced Pharma Live panel considers what is doable, and what is not, when it comes to the demands some sponsors put on CDMOs.
Experimental Pain Models — SNL Model Of Neuropathic Pain
6/20/2025

Explore how a validated Spinal Nerve Ligation (SNL) model enables effective preclinical evaluation of novel analgesics for neuropathic pain.

DRUG DISCOVERY SOLUTIONS

Specialized Services In Custom Peptide Synthesis (Solution Phase)

Our custom peptide synthesis service offers numerous options for synthesis platforms, purity levels, and modifications to meet a variety of research needs.
Bridging Molecules From Early Discovery To POC And Beyond

Learn how this partnership improves flexibility for customers, offers dedicated project teams, and enables a bespoke service that is tailored to each development program.
Aragen's Preclinical Oncology Capabilities

We provide specialized in vivo pharmacology services, offering customized solutions to support the development of immune-oncology therapies from discovery to commercialization.
Use The Right Tools To Improve Cell Lines And Production Yields

Learn about antibody production and purification, engineering antibodies for developability, and antibody humanization while also exploring an integrated pipeline that enables the direct application of machine learning tools.
A Fully Integrated Toolbox For Therapeutic Protein Expression

The GS Xceed^® Gene Expression System is a comprehensive toolbox for development of biologics that has been used to develop not only monoclonal antibodies but also a wide variety of new molecular formats.